TickerFactsScreenerDevelopers

Eledon Pharmaceuticals, Inc. (ELDN) — Operating Income

Annual figures by fiscal year, from SEC filings.

2012: -$9.65M2013: -$15.75M2014: -$23.46M2015: -$45.26M2016: -$5.13M2017: -$13.12M2018: -$14.06M2019: -$16.05M2020: -$18.46M2021: -$36.87M2022: -$88.43M2023: -$43.00M-$43.00M
2012Operating Income (USD)2023
Fiscal YearOperating IncomeChange YoY
2023-$43.00M+51.4%
2022-$88.43M-139.9%
2021-$36.87M-99.7%
2020-$18.46M-15.0%
2019-$16.05M-14.2%
2018-$14.06M-7.2%
2017-$13.12M-155.9%
2016-$5.13M+88.7%
2015-$45.26M-92.9%
2014-$23.46M-49.0%
2013-$15.75M-63.2%
2012-$9.65M—